Skip to main content
. Author manuscript; available in PMC: 2008 May 21.
Published in final edited form as: N Engl J Med. 2007 Dec 27;357(26):2657–2665. doi: 10.1056/NEJMoa065457

Table 2.

End Points.*

Variable Ablation Group (N = 64) Control Group (N = 64) Hazard Ratio (95% CI) P Value
no. of patients (%)
ICD events* 8 (12) 21 (33) 0.35 (0.15–0.78) 0.007
ICD shocks 6 (9) 20 (31) 0.27 (0.11–0.67) 0.003
ICD storms 4 (6) 12 (19) 0.30 (0.09–1.00) 0.06
Death 6 (9) 11 (17) 0.59 (0.22–1.59) 0.29
 Congestive heart failure 3 (5) 6 (9)
 Ventricular tachycardia storm 0 1 (2)
 Cancer 1 (2) 0
 Pulmonary embolism 1 (2) 0
 Unknown 1 (2) 4 (6)
*

Implantable cardioverter–defibrillator (ICD) events include ICD shocks and antitachycardia pacing.

The P value was calculated by the log-rank test.

The P value was calculated by Fisher’s exact test.

HHS Vulnerability Disclosure